SEC Comment Letter for Adicet Bio, Inc. (ACET) (CIK 0001720580) (ACET) — Mar 16, 2022
Adicet Bio, Inc. (ACET) (CIK 0001720580)
Date: March 16, 2022 · CIK: 0001720580 · Accession: 0000000000-22-002920
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-263587
Letter
United States securities and exchange commission logo March 16, 2022 Chen Schor Chief Executive Officer Adicet Bio, Inc. 200 Clarendon Street, Floor 6 Boston, Massachusetts 02116 Re:Adicet Bio, Inc. Registration Statement on Form S-3 Filed March 15, 2022 File No. 333-263587 Dear Mr. Schor: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Gabriela Morales-Rivera, Esq.
Show Raw Text
United States securities and exchange commission logo
March 16, 2022
Chen Schor
Chief Executive Officer
Adicet Bio, Inc.
200 Clarendon Street, Floor 6
Boston, Massachusetts 02116
Re:Adicet Bio, Inc.
Registration Statement on Form S-3
Filed March 15, 2022
File No. 333-263587
Dear Mr. Schor:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Gabriela Morales-Rivera, Esq.